aTyr Pharma reported $57.93M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Ardelyx USD 148.62M 18.33M Mar/2026
aTyr Pharma USD 57.93M 82.05M Mar/2026
Biogen USD 18.65B 394.9M Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Cipla INR 344.32B 15.13B Mar/2026
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Curis USD 5.46M 19.45M Dec/2025
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
Grifols EUR 6.21B 133.12M Dec/2025
Lakefront Biotherapeutics EUR 3.25B 17.5M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
United Therapeutics USD 5.9B 1.2B Mar/2026
Xoma USD 87.94M 15.5M Sep/2025